Medical technology company Haemonetics Corp. announced that it has entered into a definitive agreement to sell its Fajardo manufacturing operations to GVS, S.p.A, a provider of advanced filtration solutions for critical applications. Under the terms of the agreement, upon closing, Haemonetics will retain all intellectual property rights to its proprietary blood filters currently manufactured at […]